1-2 of 2
Mario Van Der Stelt
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Targeting IGF1R/Insr Pathway with Approved ALK-Inhibitors Overcomes Proteasome Inhibitor Resistance in Multiple Myeloma

Max Alberto Mendez-Lopez, Andrej Besse, Tiberiu Totu, Marianne Kraus, Anthonius P.A. Janssen, Marija Buljan, Mario Van Der Stelt, Lenka Besse, Christoph Driessen
Journal: Blood
Blood (2023) 142 (Supplement 1): 4663.
https://doi.org/10.1182/blood-2023-177912
Published: 2023
Journal Articles

Improving CLL Vγ9Vδ2-T–cell fitness for cellular therapy by ex vivo activation and ibrutinib

Iris de Weerdt, Tom Hofland, Roeland Lameris, Sanne Endstra, Aldo Jongejan, Perry D. Moerland, Renee C. G. de Bruin, Ester B. M. Remmerswaal, Ineke J. M. ten Berge, Nora Liu, Mario van der Stelt, Laura M. Faber, Mark-David Levin, Eric Eldering, Sanne H. Tonino, Tanja D. de Gruijl, Hans J. van der Vliet, Arnon P. Kater
Journal: Blood
Blood (2018) 132 (21): 2260–2272.
https://doi.org/10.1182/blood-2017-12-822569
Published: 2018
Includes: Supplemental data